A B S T R A C T To clarify the controversial renal action of calcitonin (CT) and a possible interrelationship between CT and parathyroid hormone, eight patients with untreated surgical hypoparathyroidism were studied. Various calcitonins, i.e. extracted porcine, synthetic porcine, synthetic human, and synthetic salmon CT in doses of 150 Medical Research Council U or 1.5 mg were infused over a 3 hr period. Subsequently, six of the same subjects received 500 USP U parathyroid extract (PTE) (Eli Lilly & Co., Indianapolis, Ind.) in 3 hr and later a combination of CT and PTE. In addition, two patients were given an infusion of ammonium phosphate with the aim of producting a phosphaturia of comparable degree as seen after CT and PTE, thus differentiating hormonal from nonhormonal influences on cation excretion. A protocol of serial clearance (C) studies using the patients as their own controls was followed. Serum and urinary inorganic phosphate (P), calcium (Ca), magnesium (Mg), sodium (Na), potassium (K), and creatinine (Cr) were determined and the clearance values calculated.
INTRODUCTION
Numerous studies have conclusively shown that CT acts on bone, but its kidney action is still far from clear (1) . Kenny and Heiskell (2) first demonstrated a phosphaturic effect in parathyroidectomized (PTX) 1 rats which was later confirmed by several groups of investigators (3) (4) (5) (6) . This effect is also obtained in dogs provided that the parathyroids are left intact (7, 8) . In the pig, only very large doses of CT provoke phosphaturia (9) and no consistent results are obtained after PTX (6, 9) . Phosphaturia in man was detected by Bijvoet, Van der Sluys Veer, and Jansen (10) and their findings were subsequently confirmed by two groups of investigators (11, 12) . However, in all these patients secondary parathyroid stimulation may have accounted for the observed increase of phosphate excretion (UP). So far only Ardaillou, Fillastre, Milhaud, Rousselet, Delaunay, and Richet (13) were able to produce a significant phosphaturia in one patient with hypoparathyroidism by infusing porcine CT, 3.2 MRC U/8 hr. At the same time, these authors observed a transient increase of urinary calcium (UCa), sodium (UNa), and chloride while no consistent changes of urinary magnesium (UMg) and potassium 11.0 (UK) were seen. Similar effects on UCa and UNa were detected by several investigators (4, 10, 11), but interferences by parathyroid hormone (PTH) were not ruled out. Since the hypoparathyroid patient of Ardaillou et al. (13) had been on a maintenance dose of vitamin D and since all their subjects were given only minute doses of extracted porcine CT, there remain doubts about the significance of the reported renal effects.
The present investigation, part of which was presented in preliminary form (14, 15) , was designed to clarify the controversy whether CT exerts a direct influence on the kidney or secondary parathyroid stimulation is responsible for the apparent renal effects. In view of this, patients with untreated surgical hypoparathyroidism received alternately CT and PTE in order to further delineate the relative importance of these factors in regulating Ca, Mg, Na, K, and P excretion. In addition, the present study aimed at excluding a secondary, nonhormonal influence of induced phosphaturia on the renal handling of cations as discussed by Eisenberg (16) . It was shown that CT and PTE in pharmacologic doses act independently on the human kidney, both hormones promoting P, Na, and K excretion while CT alone increases Cca and Cag, thus antagonizing PTE. These findings may have physiological implications regarding Ca and P homeostasis.
METHODS
Eight women with untreated surgical hypoparathyroidism were studied. Four showed episodes of frank tetany. In three, it was classified as "latent" as only Trousseau's sign was positive. In one case no tetanic symptoms could be evoked. Initial Ca values ranged from 4.3 to 7.5 mg/100 ml and inorganic P from 4.1 to 8.0 mg/100 ml (Table I) . Na and K levels were within normal range while three patients showed a slight, and one a distinct, elevation of alkaline phosphatase in the absence of liver disease. This finding was interpreted to point to an osteomalacic component, such as seen in PTX dogs (17) , rather than to an increased bone turnover. In none of the subjects was renal function seriously impaired. However, during hospitalization, patient S.S. experienced a flare-up of her chronic pyelonephritis and studies had to be stopped before completion of the protocol. In addition, because of technical difficulties with serial venepuncture, repeated catheterization, or occasional loss of specimens, complete studies were not possible in all subjects. When patient S. E. was studied for the second time, she had been on treatment with dihydrotachysterol (DHT) for several months, but for unknown reasons had relapsed into a state of latent hypocalcemic tetany subsequent to a cataract operation.
General conditions, timing of collections, and drug administration A protocol of paired clearance studies lasting from 6 a.m. to 1 p.m. was followed. All subjects were given a regular hospital diet but studies were done in the fasting state. Between experimental days, an interval of at least 1 day was observed. On experimental days, a constant urine flow was 2690 On experimental days, drugs, added to the infusion, were administered from 8 to 11 a.m. in the following order (Tables II-VI):
Control. Eight control studies with the solvent only were performed in seven subjects, leaving out S. S. in whom investigations had to be terminated prematurely; Bovine parathyroid extract. (PTE) (Subjects N. I., R. F., S. S., S. H., S. E., W. H.) 500 USP U. This dose was judged arbitrarily to be comparable to the CT doses (25) but subsequently it was found that PTE produced a more profound phosphaturia than CT.
A combination of CT and PTE. (Same subjects as PTE) Depending on the availability, porcine or human CT (Table  II) was given simultaneously with PTE. Since individual effects of various CT's were not significantly different (Fig.  4) pooling of the data seems justified.
Phosphate. 600 mg P as (NHt)2 HPOt in a solution of pH 7.4. This salt was chosen in order to avoid an additional load of cations known to interfere with tubular P transport (16) .
Since these studies were carried out over a period of 2 yr, not all four CT preparations could be administered to each individual. All peptides were generally well tolerated. However, some patients complained of abdominal discomfort and nausea immediately after starting the infusion, and sometimes blushing of the head was observed, but other signs of intolerance such as allergic reactions were not apparent.
Methods of measurement
Ultrafiltration of the 8, 9:30, 11 a.m., and 12 noon serum specimens was done by the Toribara method (26) . Urine and serum specimens were analyzed for Ca, Mg, Na, K, inorganic P, and Cr. Ca and Mg were measured in the ultrafiltrates, too. All analyses were done in duplicate. Ca and Mg were determined by the McIntyre method (27) and Na and K by conventional flame photometry. The Fiske-Subbarow procedure (28) 
Evaluation of data
Results of urinary ion excretion are expressed as deviation from the base line value, i.e., the mean of the two preceding control hours from 6 to 7 and from 7 to 8 a.m. Figures (A-change) are given in milliliters per minute. Student's Mtest for paired observations was used for statistical analysis: the area of the mean A-changes of experimental hours (from 8 a.m. to 1 p.m.) was calculated and the result was compared with the mean A-changes on control day. The levels of statistical significance as well as the mean serum values and the A-changes of Ccr are given in Tables II-VI. RESULTS In hypoparathyroid subjects, there was a marked increase in the mean value for the changes of CP (Fig.   1 ), Cc., Cmg (Fig. 2) , CNa and CK (Fig. 3) during CT infusion when compared to those occurring during a 5% fructose infusion alone. The pooled CT data are highly significant for P, Ca, and Mg (Tables II-IV) and still significant for Na and K (Tables V, VI) . Apparently, circadian variation did not influence these results (see controls). Between various CT peptides there was no significant difference of A-changes (Fig.   4 ), in particular, human CT induced the same degree of phosphaturia, calciuria, and natriuresis as the porcine preparations. Only the two patients given salmon CT, in MRC U equivalent doses, reacted with a somewhat more pronounced P, Ca, and Na excretion. However, the response of individual subjects to the different CT's varied more than the mean A-changes. This finding, and the small number of experiments done with each preparation, precludes assessment of the relative potency of the various CT's.
PTE produced the well known increase of CP in all subjects, changes being significantly greater than with CT. Simultaneously, there was an increment of CN. and CK; the sodium figure was not statistically significant. Cmg decreased significantly and Cc. insignificantly.
Neither the CT nor the PTE effects can be attributed to changes of the GFR. While urinary electrolytes were rising, Ccr remained stable or tended to fall (Fig. 1) .
However, deviations from the zero line are not statistically significant (Table II) . Similarly, the changes of serum electrolytes were too small to explain the changes of the clearance figures. Even the largest difference between the initial and the final serum P with PTE was not statistically significant (Table II) . When CT was added to PTE, the changes of CP, CNa, and CK were not appreciably influenced, but the combination of the two hormones resulted in a summation of the individual effects on Cc. and CMg. As demonChanges of Potassium Excretion strated in Fig. 2 , the calculated and the observed excretion pattern can nearly be superimposed; the differences are not statistically significant (Tables III, IV) .
The phosphate infusion produced a phosphaturia of 
DISCUSSION
The present studies document that pharmacologic doses of CT increase the renal clearance of P, Na, K, Ca, and Mg in hypoparathyroid, human patients. This effect, as well as the observed response to PTE, cannot satisfactorily be explained on the basis of an altered filtered load of these ions. While the urinary electrolytes were rising, Cc, remained stable or tended to fall. This finding rules out a significant hemodynamic effect of PTE on GFR such as has been reported in dogs (30) . Similarly, serum electrolytes did not show a significant variation. Therefore, CT appears to exert direct renal effects. Interestingly enough, this kidney response seems to be species dependent: in the PTX dog porcine CT does not produce phosphaturia (6, 8) which was seen in all our hypoparathyroid subjects. All CT's including the human peptide provoked this response. As demonstrated also by direct injection of CT into one renal artery (31), this effect is not mediated through the parathyroids in man. If this phenomenon, observed after pharmacologic doses, has physiologic significance (see below), CT may play an important role in the maintenance of P homeostasis, to some extent in concert with PTH. The plasma Ca lowering CT effect is proportional to the starting P level (32) , and in dogs, the P depressing effect is more prominent (33). Jowsey and Detenbeck (25) have shown that in a state of CT deficiency P is stored in soft tissues. After administration of the hormone this P is released immediately into the ECF, with a consequent initial rise of plasma P. In a close temporal relationship to the change of P excretion, all CT peptides produced a significant increase of CNa and CK. The natriuretic effect seems to be a regular finding both in experimental animals (4), in normal subjects, and in patients with metabolic bone disease (10) (11) (12) 35 ). That we are dealing with a true hormonal effect was shown in the two patients given an ammonium phosphate infusion: the same degree of phosphaturia was obtained without significant changes of blood pH and serum cations, but the CP peak was not associated with a relevant increase of cation excretion (Fig. 5) . Prolonged administration of CT, which in our short-term experiments acted as a diuretic, may therefore be responsible for sodium and water loss recently observed in two CT-treated osteoporotic patients (36) .
All CT peptides produced an increase of Cc. and Cxg in our patients and the combined administration of CT and PTE resulted in a summation of individual hormone effects (Fig. 2) . These results were obtained with pharmacologic doses of CT and PTE, but Ardaillou et al. (13) reported a significant increase of UCa in human subjects who were given an infusion with only 0.4 MRC U porcine CT/hr. This figure approaches measured hormone quantities secreted in the pig (37) . Hence, our data might have physiological significance. They are at variance with the data of Rasmussen, Anast, and Arnaud (4) who found a reduction of UCa and UMg in young rats given CT. The likely explanation for this discrepancy lies with the state of bone remodeling. In the growing animal, the CT bone effect prevails over the kidney response which in turn becomes more prominent in a state of low bone turnover (38) such as in mature adults and hypoparathyroidism (39, 40) . Our data tend to support the original concept of Copp, Cameron, Cheney, Davidson, and Henze (41 ) who postulated that CT acts as a regulator of Ca homeostasis in concert with PTH. Earlier, we have reported experiments in man suggesting that only a limited fraction of extracellular Ca is available for CT action (42) . The immediate and transitory fall of serum Ca after CT can best be explained by influences on the incorporation of Ca into a labile bone pool (43) and/or on the renal Ca transport. The renal Ca effect of CT becomes even more important if one considers the recently appreciated prominent role the kidney seems to play in Ca homeostasis (44) . Hence, PTH and CT appear to be true antagonists: PTH increases blood Ca by facilitating intestinal and tubular transport and mobilizing Ca from the bone. CT on the other hand works in opposition by accelerating Ca entry into bone and enhancing renal Ca elimination. CT would then be of therapeutic use only in conditions resembling the growth period, i.e., states with high bone turnover, such as Paget's disease (36) . In situations with low bone turnover, e.g., senile osteoporosis, prolonged CT administration may lead to a progressive Ca loss already reported in two osteoporotic subjects (36) . It seems doubtful that even the minimal CT doses proposed for the long-term treatment of osteoporosis (13, 31) are low enough to protect the bone from Ca depletion without inducing renal Ca loss. However, one should keep in mind that acute effects, such as reported in this paper, do not necessarily apply to prolonged administration of CT.
